Cannabis operators have spent five years waiting for Washington to fix the market. The hearing that just wrapped up didn't fix it. Cannabis captive insurance is the part of your cost structure you actually control, and it was never something you needed a ruling to act on.
The Hearing Ended. The Uncertainty Didn't.
On July 15, 2026, the DEA's hearing on recategorizing cannabis from Schedule I to Schedule III concluded after weeks of testimony. Post-hearing briefs are due August 17. After that, the presiding judge writes a recommendation, with no announced timeline. After that, there will be more news, and possibly even more litigation. What do we know? Not much! But, we can say with confidence that medical cannabis has been moved from Schedule I to Schedule III. Adult-use cannabis remains Schedule I.
We can also say this: waiting for a rule with no date attached to it is not a strategy. It is a delay, and it is optional.
The Volatility You Didn't Vote For
Commercial insurance for cannabis was never built to serve the industry's actual risk profile. It was built to manage carrier discomfort with a federally restricted product, and the pricing reflects that discomfort, not your operation.
Most commercial cannabis policies come from a small group of surplus lines carriers who price the industry as a block. A processor with five clean years of loss history pays rates built around the worst actors in the sector, because there is no mechanism in the commercial market to reward a specific track record. Coverage restrictions compound the problem: product liability, business interruption from a forced closure, crop and inventory loss, and regulatory defense costs are routinely excluded or thinly sublimited. In 2023, an Arkansas medical cannabis grower, River Valley Production, sued its insurer for $300,000 after its claims administrator denied a crop-damage claim, citing policy exclusions for equipment breakdown, crop loss, and temperature changes [4]. Whatever the case's outcome, it's a real example of exactly the coverage gap operators run into. When a carrier exits a state, which has happened repeatedly over the past five years, operators are pushed into emergency renewals at whatever price the remaining market will bear.
What Actually Builds Stability
A captive insurance company is an insurance company the business owner owns and controls. The business writes the terms because the business owns the insurer. Instead of paying premiums to a third-party carrier that prices you against the industry's worst claims history, you pay premiums into a company you own, priced against your own claims history instead.
Premiums paid into the captive stay on the captive's balance sheet as reserves. In years with low claims, which for well-run operations are most years, the surplus stays with the owner instead of flowing to a carrier's profit margin. In practice, that means your company keeps the underwriting profit that would otherwise have gone to someone else. The captive can also be structured to cover the lines where the commercial market prices irrationally for cannabis: product liability, business interruption, crop and inventory risk, and regulatory defense.
The Numbers, Not the Hype
A cannabis operator moving $250,000 of annual insurance spend into a well-structured single-parent captive can accumulate $1 million to $2 million in owned reserves within five years, depending on claims experience. That figure is illustrative, not a guarantee, and it depends heavily on the specific operation's loss history and structure. The more effectively your company limits losses, the more of that reserve it keeps. What it demonstrates directionally holds regardless of the exact number: dollars that were flowing to a carrier's surplus become dollars building equity on your own balance sheet.
Under IRC Section 831(b), premiums paid to a qualifying captive are deductible by the parent company, and captive underwriting income accumulates tax-deferred. How that sits alongside 280E depends on what you sell. If your business is adult-use only, cannabis remains Schedule I and 280E still bars you from deducting ordinary business expenses, only cost of goods sold is deductible, so a captive changes your insurance economics but not your 280E exposure. If your business operates under a state medical license, the April 2026 DOJ order moved medical cannabis to Schedule III, and Treasury and the IRS have said rescheduling generally removes 280E as a bar to deductions for that part of your business, though detailed guidance for operators selling into both markets hasn't been issued yet [2]. Either way, this sits alongside, not in place of, the tax planning your CPA is already doing.
Is Your Operation Ready?
For businesses, $200,000 or more in annual insurance spend is the general guideline where a captive feasibility study starts to demonstrate real economic value. That is a guideline, not a hard rule, and it often runs lower for cannabis operations specifically, given how uninsured and expensive cannabis risk already is compared to other industries. Operations with strong safety and inventory-control records, or with real exposure to product liability and regulatory defense costs, can clear the threshold at lower spend levels.
The first step is simply a conversation: a no-cost policy analysis that shows whether your numbers clear the threshold and what a captive could realistically change. The formal feasibility study, the first paid step in the process, comes after that. Once a captive is formed, the annual actuarial reviews, domicile compliance, and governance work are handled by your captive manager, not by you. It's real work, but it isn't a lift your team has to carry.
3F Captive Services works with cannabis operators to assess feasibility and model the financial case specific to your revenue and risk profile.
Contact 3F Captive Services for a no-cost policy analysis. We'll identify the coverage gaps in your current program and model what a captive structure could build for your operation.
⚠ This post is for informational purposes only and does not constitute insurance, legal, or tax advice. Regulatory status, coverage terms, and captive feasibility vary by operation and jurisdiction. Consult qualified insurance, legal, and tax advisors regarding your specific situation.
Sources
[1] Marijuana Moment. "Federal Marijuana Rescheduling Hearing Wraps Up, With DEA Judge Laying Out Next Steps." July 16, 2026. https://www.marijuanamoment.net/federal-marijuana-rescheduling-hearing-wraps-up-with-dea-judge-laying-out-next-steps/
[2] Marijuana Moment. "Feds Announce Marijuana Industry Tax Guidance Is Coming As Rescheduling Takes Effect." April 23, 2026. https://www.marijuanamoment.net/feds-announce-marijuana-industry-tax-guidance-is-coming-as-rescheduling-takes-effect/
[3] Internal Revenue Code Section 831(b). Captive insurance company tax treatment for qualifying small insurance companies.
[4] MJBizDaily. "Arkansas Cannabis Grower Suing Insurer After Claim Denied." March 16, 2023 (citing Law360). https://mjbizdaily.com/news/arkansas-cannabis-grower-suing-insurer-after-claim-denied/356444/
Discover Tailored Insurance Solutions
Unlock the potential of customized captive insurance designed specifically for your unique business needs.